Sutter Rock Capital Corp. (NASDAQ:SSSS) Major Shareholder Robert S. Birch Purchases 50,000 Shares

Share on StockTwits

Sutter Rock Capital Corp. (NASDAQ:SSSS) major shareholder Robert S. Birch purchased 50,000 shares of the company’s stock in a transaction on Friday, March 20th. The shares were purchased at an average price of $4.37 per share, with a total value of $218,500.00. Following the completion of the purchase, the insider now directly owns 2,196,176 shares of the company’s stock, valued at $9,597,289.12. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Shares of NASDAQ SSSS opened at $4.92 on Friday. Sutter Rock Capital Corp. has a 1-year low of $3.60 and a 1-year high of $8.39. The business has a 50-day moving average of $5.81 and a 200-day moving average of $6.39. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.94 and a quick ratio of 0.94. The company has a market capitalization of $89.58 million and a price-to-earnings ratio of 4.43.

Sutter Rock Capital (NASDAQ:SSSS) last issued its earnings results on Tuesday, March 10th. The company reported ($0.14) earnings per share for the quarter. Sutter Rock Capital had a negative return on equity of 4.51% and a net margin of 1,602.27%. The company had revenue of $0.40 million during the quarter.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Bank of New York Mellon Corp purchased a new stake in shares of Sutter Rock Capital in the fourth quarter worth about $101,000. Bulldog Investors LLC purchased a new stake in shares of Sutter Rock Capital in the fourth quarter worth about $625,000. Oxford Asset Management LLP purchased a new stake in shares of Sutter Rock Capital in the fourth quarter worth about $109,000. Trexquant Investment LP boosted its position in shares of Sutter Rock Capital by 28.1% in the fourth quarter. Trexquant Investment LP now owns 17,602 shares of the company’s stock worth $115,000 after buying an additional 3,866 shares during the period. Finally, Virtu Financial LLC purchased a new stake in shares of Sutter Rock Capital in the fourth quarter worth about $69,000. 21.23% of the stock is owned by institutional investors.

Separately, Barrington Research reaffirmed a “buy” rating and issued a $10.00 target price on shares of Sutter Rock Capital in a research report on Thursday, March 12th.

About Sutter Rock Capital

Sutter Rock Capital Corp. is specializing in growth capital, B round and beyond, emerging growth, and pre-IPO investments in late stage venture-backed private companies. It makes direct (primary rounds) investments in companies and also makes secondary direct investments. The fund may also invest in select publicly-traded equity securities of companies that otherwise meet its investment criteria.

Featured Story: Reverse Stock Split

Insider Buying and Selling by Quarter for Sutter Rock Capital (NASDAQ:SSSS)

Receive News & Ratings for Sutter Rock Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sutter Rock Capital and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

514,848 Shares in Charles River Laboratories Intl. Inc  Bought by Norges Bank
514,848 Shares in Charles River Laboratories Intl. Inc Bought by Norges Bank
Cardiovascular Systems  Price Target Cut to $54.00
Cardiovascular Systems Price Target Cut to $54.00
Ladenburg Thalmann Financial Services Inc. Reduces Stake in Otter Tail Co.
Ladenburg Thalmann Financial Services Inc. Reduces Stake in Otter Tail Co.
Janus Henderson Group PLC Takes $2.22 Million Position in Eagle Materials, Inc.
Janus Henderson Group PLC Takes $2.22 Million Position in Eagle Materials, Inc.
Macquarie Group Ltd. Buys 9,800 Shares of Textron Inc.
Macquarie Group Ltd. Buys 9,800 Shares of Textron Inc.
Corcept Therapeutics Incorporated  Shares Bought by Profund Advisors LLC
Corcept Therapeutics Incorporated Shares Bought by Profund Advisors LLC


 
© 2006-2020 Zolmax.